See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Francis
London Marathon
Social Media
Vatican
NFL
Soccer
Real Madrid
Donald Trump
Catholic Church
Natural Disasters
Premier League
Military
Published • loading... • Updated

Bristol-Myers Squibb, Sanofi, and Merck and Co. discuss tariffs and manufacturing in quarterly financial call

Summary by BioProcess International
With 25% pharma tariffs on the table, biopharma companies discuss strategy and damage mitigation in their recent financial calls with investors.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
BioProcess InternationalBioProcess International

Bristol-Myers Squibb, Sanofi, and Merck and Co. discuss tariffs and manufacturing in quarterly financial call

With 25% pharma tariffs on the table, biopharma companies discuss strategy and damage mitigation in their recent financial calls with investors.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

BioProcess International broke the news in on Thursday, April 24, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Tariffs

Tariffs

New Jersey

New Jersey

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal